Eupraxia Pharmaceuticals Inc.

EPRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.64

+$0.06 (+0.70%)

At close: Sep 21, 2026, 4:00 PM ET

$8.64

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.70%

(1D)

Rating

Updated: Sep 4, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $289.27M

1D Range

8.51 8.76

52W Range

5.16 9.32

Valuation (TTM)

PE -8.39

PB 2.21

EV/EBITDA -3.27

Valuation (NTM)

Forward PE N/A

Forward PEG -0.59

Price Target $17

Cash Flow

FCF Yield -12.8%

SBC Adj. FCF Yield -12.9%

SBC Impact -0.9%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -21.4% | 7.2%

FCF 3Y | 5Y -28.2% | -22.8%

Returns

ROA -35.7%

ROE -45.3%

ROIC -43.1%

Financial Health

Net Cash

$133.4M

Current Ratio 16.00

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technolo...

Sector Healthcare

Industry Biotechnology

Employees 49

IPO Date Apr 4, 2024

Website www.eupraxiapharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$17

Upside

+96.76%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞